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Abstract 
Background: This research was aimed to critically evaluate, under the light of the available scientific evidence, the 
oral care protocols recommended by different hospitals in head and neck cancer (HNC) patients under radiation 
therapy.
Material and Methods: A questionnaire requesting all the relevant information for the oral care of these patients was 
sent to the 9 University Hospitals in Madrid. The answers were categorized and analyzed. In addition, an electronic 
search was conducted to identify the most relevant papers (systematic reviews [SR] and randomized clinical trials 
[RCTs]) assessing oral care protocols for patients treated for HNC with radiation therapy.
Results: Eight out of nine centers answered the questionnaire and the retrieved information was tabulated and 
compared. These recommendations were analyzed by a computerized search on MEDLINE and the Cochrane Oral 
Health Collaboration Database. The results of the analysis clearly shown a great heterogeneity, in terms of oral 
health care protocols, regarding the management of irradiated patients (for HNC) within the Hospitals of Madrid 
region. In addition, some of the recommendations lack solid scientific support. 
Conclusions: The present survey revealed that the recommendations provided by the different hospitals were clearly 
different. The available evidence, supported by SR and RCTs, suggested the need of an oral assessment before can-
cer treatment, in order to prevent and treat dental pathologies and avoiding potential complications; during cancer 
treatment, it is relevant monitoring the patient in order to decrease the severity of the side effects, and to avoid 
any tooth extraction or surgery and special attention should be paid to mucositis, xerostomia and candidiasis; after 
cancer treatment, the following are relevant aspects: the risk of osteoradionecrosis, trismus, caries and the risks 
associated to dental implants. 
Key words: Head and neck cancer, supportive care in cancer, radiotherapy complications, management and oral 
care on cancer treatment.
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Introduction
The treatment of patients suffering from head and neck 
cancer (HNC) is increasingly more effective. The Natio-
nal Cancer Data Base reflects an increase in the overall 
survival from 45.5% in 1994 to 53.4% in 2005, with con-
current chemo-radiotherapy (1). These therapies, howe-
ver, are frequently associated with side effects, both in 
short- and long-term. Among these side effects, oral pa-
thologies are frequent and a source of impairment of the 
patient’s health and wellbeing (2). Even though there are 
effective preventive and therapeutic agents to manage 
these oral complications, there are no standard proto-
cols with evidence based efficacy and the collaboration 
between the different medical specialists treating these 
patients and oral health personnel when these patients 
are hospitalized is usually deficient (3). It is therefore 
the aim of this descriptive study to assess the existing 
oral care protocols for the treatment of these patients in a 
public health hospital network, to analyze their rationale 
and scientific base and to ultimately provide recommen-
dations based on evidence-based efficacy.
Material and Methods 
Two approaches to identify protocols of oral care for 
irradiated HCN patients were performed, namely a ques-
tionnaire for Hospital and a literature review.
-Questionnaire: The Radiotherapy units of the Oncology 
Services of the University Public Hospital Network in 
the Region of Madrid (Spain) were contacted (by mail) 
requesting their protocols in oral care for the treatment 
of the HNC patients, before, during and after the appli-
cation of radiotherapy. The received information was 
properly tabulated and categorized into the different 
components of the specific protocol.
-Literature review: The evidence base of these recom-
mendations was analyzed by a computerized search on 
MEDLINE and the Cochrane Oral Health Collaboration 
Database, analyzing the efficacy of the different specific 
therapies with special focus on randomized clinical trials 
(RCTs) and systematic reviews (SRs) that could help in 
the support the proposed recommendations.
Results
▪ Results: questionnaire
Eight of the nine (88.8%) University Hospitals in the 
Region of Madrid answered the request (Ramón y Ca-
jal, Puerta de Hierro, Clínico San Carlos, 12 de Octubre, 
Gregorio Marañón, La Princesa, La Paz, Hospital de 
Madrid Clara Campal). In table 1, different oral care the-
rapeutic recommendations provided by each hospital are 
listed, being the most frequent advices: assessment by 
dentist, use of alcohol-free antiseptics, adequate hygiene 
oral (soft toothbrush and fluoride toothpaste), nutritional 
recommendations, and to avoid drinking and smoking. 
Regarding the use of rinses, some centers recommended 
a particular active agent, while others do not specify the 
agent or the frequency of use. 
Table 2 shows the recommendations for the treatment of 
mucositis, with seven centers (87.0%) recommending a 
mixed solution with chamomile and/or bicarbonate. Five 
centers (62.5%) recommended, in case of pain, the use 
of analgesics and anti-inflammatory, two centers (25%) 
recommended topical anesthetics. Four centers (50%) 
recommended nutritional advice through a nutritionist. 
One center (12.5%) recommended coating agents of the 
mucosa. In case of candidiasis only one hospital (12,5%) 
recommended treatment.
Table 3 lists the recommendations in case of xerostomia. 
Five hospitals (62.5%) included a general definition of 
this condition and reported general measures as the in-
crease of water intake and changes in the diet. In four 
hospitals (50%) different rinsing solutions were recom-
mended. In three hospitals (37.5%) the use of chewing 
gum, ice cubes, moisturizing lip products and saliva 
substitutes were recommended. In one hospital (12.5%), 
the salivary function was analyzed.
▪ Results: literature review
• Before cancer treatment
- It is highly recommended to perform an oral examina-
tion and carry out the proper treatments (if necessary) 
before the cancer treatment starts (4,5). In this way, the 
oral problems associated with radiotherapy can be pre-
vented or minimized through the appropriate manage-
ment, as suggested by the consensus of the National Ins-
titute of Health (1989) (4,6). Clinical and radiographic 
examination is crucial in order to determine the presence 
of periapical pathology and to evaluate the periodontal 
and oral health status. For this purpose, both panoramic 
and selected periapical radiographs should be carried out 
before radiotherapy treatment (RT).
- It seems essential to have a consultation with the 
patient’s physician to find out more in order to gain a 
better grasp of the RT (external beam or radioactive im-
plant), RT characteristics (location, size of the treatment 
field, RT fractionation, total dose), that are fundamental 
for the overall risk assessment and scheduling any dental 
intervention required (3).
- Oral hygiene protocols may decrease the incidence, se-
verity and duration of the oral complications. A soft too-
thbrush and a fluoride toothpaste or gel should be recom-
mended to prevent the accumulation of plaque and tooth 
demineralization (3). The use of plaque revealers may be 
useful in order to help the patient in identifying problema-
tic areas. The proper brushing technique must be tailored 
for each patient, as well as the description of wrong habits 
and the importance of the control of interdental plaque, 
either with floss or interdental brushes (7).
- The use of products containing fluoride reduces the risk 
of caries in patients under RT treatment (4,5). To pre-
vent “rampant” tooth decay, custom trays with neutral 
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Oral Care H1 H2 H3 H4 H5 H6 H7 H8 
Assessment by dentist. 
When? 
Yes
Ns
Yes
BT
Yes
BT,
DT,
AT 
No Yes 
BT, AT 
No Yes 
Ns
No
Fluoride application Yes Yes No No No Yes No No 
Antiseptics
Specified? 
Yes
Ns
Yes
CHX
No Yes 
Ns
Yes
BT, DT, AT 
Yes
CHX
Yes
Chamomile 
No
Alcohol-free 
antiseptics
Yes Yes No Yes Yes Yes Yes No 
Oral hygiene 
techniques 
Yes Yes 
3times/day 
Yes
BT,
DT,
AT 
Yes Yes 
BT, DT, AT: 3-
4times/day, 2-
3min 
Yes Yes 
Tongue hygiene 
No
Soft toothbrush Yes Yes Yes Yes Yes 
BT, DT, AT 
Yes Yes No 
Fluoride toothpaste No Yes Yes Yes Yes 
BT, DT, AT 
Yes Yes No 
Interdental hygiene No No No No Yes 
BT, DT, AT: 
dental floss 
1/day 
Yes No No 
Dental prophylaxis No No No No Yes 
BT, AT: every 
3-6months 
No No No 
Fillings No Yes 
BT
No No Yes 
BT, AT 
No No No 
Periodontal Treatment No Yes, 
BT
No No Yes 
BT, AT 
No No No 
Dental prosthesis 
(recommendations) 
No No No No Yes 
BT: check fit. 
AT: do not use 
removable 
prosthesis until 
acute symptoms 
disappear 
Yes
BT: check fit 
Do not use if 
inadequate
fitting
No
Temporomandibular 
joint
(recommendations) 
No No No No Yes 
BT,AT:  check 
mobility and 
daily
rehabilitation
exercises 
Yes
BT, DT, AT: 
mandibular 
exercises 
Yes
Rehabilitation
exercises 
No
Tooth extraction 
(recommendations) 
No Yes 
BT: if poor 
prognosis; DT: 
avoid. AT: after 
1year (minimal 
trauma, primary 
wound closure, 
ATB) 
No No Yes 
BT: 2 weeks; 
AT: after 1year, 
if required 
HBO, ATB 
Yes
BT: if poor 
prognosis. DT: 
avoid. AT: after 
1year
(hemogram, 
coagulation
study; HBO in 
cases of 
RT>60Gy; 
minimal 
trauma; ATB) 
No No 
Nutritionist
(recommendations) 
Yes
Solid foods, 
mashed; avoid 
salted, acid, 
spicy foods; 
supplemented 
glutamine 
Yes
No cariogenic 
diet
No Yes Yes 
BT and DT: 
healthy
balanced diet; 
proper 
hydration 
No Yes 
No cariogenic 
diet
No
Avoid drinking and 
smoking 
No Yes Yes Yes Yes 
BT, DT, AT 
Yes Yes No 
ORN
(recommendations) 
No No No No Yes 
AT: surgical 
resection and 
reconstruction 
Yes
Remove 
irritating
factors; HBO; 
Surgical
Resection
No No 

Table 1. Recommendations, for oral care, as administered by the different surveyed centers.
***H1: Ramón y Cajal; H2: Puerta de Hierro; H3: Clara Campal; H4: Clínico San Carlos; H5: Gregorio Marañón; H6: 12 Octubre; H7: La 
Princesa; H8: La Paz. 
HBO, hyperbaric oxygen; RT, radiotherapy; CHX, Chlorhexidine; ATB, antibiotic prophylaxis, ORN, osteoradionecrosis; Ns, not specified; BT, 
Before Treatment; DT, During Treatment; AT, After Treatment.
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sodium fluoride gel (1.1%) should be applied for 5 min 
on a daily basis, beginning the first day of RT and con-
tinuing on a daily basis while dry mouth and saliva flow 
remains low (3).
- Supragingival prophylaxis or subgingival scaling (in 
patients with periodontitis) (4).
- Treatment of carious or endodontic lesions before can-
cer treatment (4).
- It is convenient to perform a sialometry to check the 
salivary flow rate (both resting and stimulated) since it 
can be altered during treatment.
- Adjustment or modification of removable prosthetics 
that do not properly fit, in order to avoid erosions or mu-
cosal lesions.
- Tooth extractions: the criteria for tooth extractions are 
not universally accepted and should be subjected to clini-
cal judgment (4). Tooth extraction must be non-traumatic 
and obtaining primary closure, allow ten days between 
Advice H1 H2 H3 H4 H5 H6 H7 H8 
MUCOSITIS 
Oral Rinses Water + 
Chamomile + 
Bicarbonate 
No  Chamomile 
or
Bicarbonate 
Water + 
Bicarbonate 
Water and salt 
or bicarbonate 
Boiled 
water + 
Bicarbonate 
+
Anesthetic 
Saline 
serum or 
bicarbonate 
or
chamomile 
Boiled water 
+ salt + 
bicarbonate+ 
fortecortin + 
Scandinibsa
+ mycostatin 
Pain 
Control
Analgesics & 
anti-
inflammatories. 
Opiates 
Analgesics & 
anti-
inflammatories 
No  No  Analgesics & 
anti-
inflammatories 
Analgesics. 
Opiates 
Yes No  
Gelclair® Yes Yes  No No  No   No  No  No 
Information
mucositis 
No  Yes No  No   No Yes Yes No  
 CHX rinses No  Yes No  No   No No No No 
Nutritionist No  Yes 
Ns 
Yes
Soft diet, 
avoid spicy 
or acid 
foods.
Dietary 
supplements
No  No  Yes 
Ns 
Yes
Avoid
certain 
foods.
Dietary 
supplements
No  
Topical
Anesthetics  
No  No  No  No  Lidocaine 2% Lidocaine 
2%
No  No  
Mucosal 
coating 
agents  
No  No  No  No  Yes No  No   No 
CANDIDIASIS  
Fluconazole No  No  No  No  Yes No  No No 
Itraconazole No  No  No No  Yes No  No No 
Miconazole No  No   No No  No  No  No No 
Nystatin No   No  No No  No  No  No No 
Prostheses 
hygiene 
No  No  No  No  No  No  No No 

Table 2. Recommendations, in case of mucositis and candidiasis, as administered by the different surveyed centers.
H1: Ramón y Cajal; H2: Puerta de Hierro; H3: Clara Campal; H4: Clínico San Carlos; H5: Gregorio Marañón; H6: 12 Octubre: H7: La 
Princesa; H8: La Paz.
CHX, chlorhexidine; Ns. Not specified.
extraction date and granulocyte count <500/mm3, avoid 
intra-alveolar hemostatic packing agents, and platelet 
transfusion if platelet count <40,000/mm3, or prophylactic 
antibiotics if granulocyte count <2,000/mm3 (4).
• During cancer treatment
Monitoring the patients during cancer treatment must be 
increased in order to decrease the severity of the side 
effects. It is necessary to instruct the patient to avoid any 
tooth extraction or oral surgery during cancer treatment.
During cancer treatment, when the mechanical control 
of the plaque becomes more difficult, the use of a che-
mical plaque control with chlorhexidine (CHX) mouth 
rinses can be beneficial (8,9) to prevent the occurrence 
of microbial infections, gingival inflammation, bleeding 
and to reduce the risk of caries (4,10). Mouth rinses with 
0.12% CHX have antibacterial and antifungal properties, 
resulting in an effective anti-plaque and anti-gingivitis 
effects. It should be used in formulations with adequate 
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XEROSTOMIA H1 H2 H3 H4 H5 H6 H7 H8 
General
Information 
No  Yes Yes Yes No  Yes Yes No  
Increase water 
intake 
No  No Yes Yes Yes Yes Yes No  
Candy or gum        No No Yes Yes No  No  Yes No  
Ice  No No Yes Yes No  No  Yes No  
Rinses Yes 
Xerostom® 
No  Yes 
Alcohol-
free
Yes
Water + 
Lemon
or thyme 
infusions
Yes
Solutions
with salt or 
bicarbonate 
No   No No 
Moisturizing lip 
products
No  No Yes No  Yes Yes No  No 
Mineralizing 
solution 
No  No No No Yes No No No 
Lubricant 
(moisten the 
mouth)
 No No No No Yes No No No 
Salivary 
substitutes 
No No No No Yes Yes Yes No 
Nutrition No No Yes 
Mashed 
foods at 
ambient 
temperature. 
Yes
Soft diet. 
Avoid
dry 
foods.
Yes Yes Soft 
diet.
Avoid
spicy 
foods.
No  
Sialometry  No No No No Yes No No No 
Sialogogues No  No No No No Yes 
Pilocarpin® 
Yes No  

Table 3. Recommendations, in cases of xerostomia, as administered by the different surveyed centers.
H1: Ramón y Cajal; H2: Puerta de Hierro; H3: Clara Campal; H4: Clínico San Carlos; H5: Gregorio Marañón; H6: 12 Octubre; 
H7: La Princesa; H8: La Paz.
bioavailability and without alcohol to avoid tissue irri-
tation (3,10).
* During cancer treatment: mucositis
- The patient must be informed about the possibility that 
mucositis can occur and the available measures to alle-
viate it.
- Maintaining proper oral hygiene can reduce its inci-
dence (3,11).
- Avoid smoking and drinking alcohol.
- Remove the prostheses during the acute phase of mu-
cositis, in order to avoid further complications.
- Nutritional support and appropriate hydration (5): small 
and frequent meals are recommended, favoring foods 
rich in proteins and calories. The use of foods having 
soft, pasty or semi-liquid consistency, easy to chew and 
swallow, with mild flavors at room temperature, are sug-
gested; excluding those spicy, salty, and acidic. It is also 
helpful to promote liquid intake (2-3 liters/day) (12).
- Pain control: pain can be relieved with the use of to-
pical or systemic anesthetics. In case of mucositis with 
mild to moderate pain, topical anesthetics such as ben-
zocaine or viscous lidocaine can be used. Topical ste-
roids (diphenhydramine or dexamethasone) are someti-
mes used to reduce the inflammatory reaction of the oral 
mucosa (6). Rinses with 0.5% doxepin may be effective 
in treating pain from oral mucositis (11,13). In the most 
severe cases, rinses with 2% morphine can keep pain un-
der control (11,13,14).
- Treatment with low-intensity laser reduces the severity 
of mucositis, as it relieves or cures ulcers (13-16).
- Interventions such as cryotherapy (“chips” of ice) and 
Keratinocyte Growth Factor (Palifermin®, Swedish 
Orphan Biovitrum. Stockholm, Sweden) have shown 
evidences of being beneficial in preventing mucositis 
in patients irradiated for HNC (2,13). There is strong 
evidence in favor of 0.5% benzydamine hydrochloride 
mouth rinses for the prevention of oral mucositis in pa-
tients receiving moderate doses of RT for HNC (up to 50 
Gy) with or without chemotherapy (CT) (6,13).
* During cancer treatment: xerostomia
Patients with xerostomia should increase fluid intake to 
25-30 ml/kg/day, preferably with acid juices to stimulate 
saliva production; the meals should be moist, soft, with 
sauces, in the shape of puree, broths and ice creams; a 
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humidifier should be used at night; avoiding smoking 
and drinking alcohol (12). The intensity-modulated ra-
diotherapy (IMRT) can reduce the adverse effect of xe-
rostomia (5,17). There is no strong evidence for a spe-
cific topical treatment being effective for treating the 
symptoms of dry mouth (18). In patients with residual 
salivary function, saliva stimulants (sugarless gum, pilo-
carpine and cevamaline, that increase the salivary fluid 
in patients with radio-induced xerostomia) may be use-
ful (5). Patients without salivary function can get bene-
fits from the use of artificial saliva or other fluids to keep 
the mucosa hydrated.
* During cancer treatment: candidiasis
For the prevention of oral candidiasis, there is strong 
evidence that suggests that those drugs totally (flucona-
zole, ketoconazole, itraconazole) or partially (miconazo-
le, clotrimazole) absorbed by the gastrointestinal tract, 
can prevent candidiasis in patients irradiated for HNC. 
There is also evidence that these drugs are more effecti-
ve than drugs not absorbed by the gastrointestinal tract 
(19,20).
• After cancer treatment
A program of post-RT visits shall be scheduled, on a 
tailored basis, to manage chronic complications and to 
solve any oral condition that had been postponed (4).
* After cancer treatment: tooth extraction and osteora-
dionecrosis
It has been known for a long time that ionizing irra-
diation, among other factors, can delay skin and bone 
wound healing and that the healing process is closely 
related to the radiation doses. After tooth extraction 
in irradiated HNC patients, the bone healing could be 
delayed or impaired (21). The impact of osteoradione-
crosis (ORN) is lower in patients irradiated by IMRT. 
It is more frequent in the mandible than in the maxilla. 
This process can occur spontaneously or it can be cau-
sed by trauma (e. g. tooth extraction) or oral infections 
(4,22). The hyperbaric oxygen (HBO) is considered as 
an adjunctive therapy for ORN, normally in combina-
tion with surgery, and it has been associated with bet-
ter success rates than surgery alone (3) and reduce the 
risk of ORN following tooth extraction in the irradiated 
area (23).
* After cancer treatment: caries, Plaque (PI) and Gingi-
val (GI) indices
Patients after antineoplastic therapy had higher PI and 
GI than healthy patients. The prevalence of dental caries 
in post-RT and post-chemo-RT patients was 24% and 
21.4%, respectively (4). The use of fluoride products re-
duces caries activity in post-RT patients. The use of CHX 
rinses reduces plaque scores and oral mutans streptococ-
ci scores. With dental restorations, conventional glass 
ionomer cements performed poorer than the comparati-
ve materials, specifically amalgam, resin-modified glass 
ionomer and composite resin restorations (4).
* After cancer treatment: trismus
The prevalence is lower in patients receiving IMRT. 
There are no clear guidelines for trismus prevention and/
or treatment (24). The treatment is physical, with motion 
exercises to maintain and relax, manual stretching and 
joint distraction. The trismus in these patients usually 
has refractory nature and treatment with electrotherapy 
and pentoxifylline can improve the established trismus 
(25). 
* After cancer treatment: rehabilitation with dental im-
plants
There is consistent scientific evidence to demonstrate 
that there is a higher failure rate in patients previously 
treated with RT (26,27). This should be interpreted with 
caution, due to the difficulties in achieving reproduci-
ble experiments and the very limited literature available. 
According to a narrative review (28), different factors 
must be considered: RT type, dose, fractionation, use of 
chemotherapy, risk of recurrence, anatomical region for 
implant placement, time from RT to implant placement 
[many researchers have recommended to wait at least 
12 months after RT (29) although other researchers have 
recommended at least 2 years]. Other factors that may 
be relevant including the time between the 1st and 2nd 
phase (osseointegration in the irradiated tissue may be 
slower, so the time between phases should be extended 
to 4-8 months), prosthetic retention system used, loading 
factors, management of soft tissues, and the risk of ORN. 
HBO therapy in irradiated patients requiring dental im-
plants may not offer any appreciable clinical benefits. 
Additional RCTs are necessary in order to ascertain the 
effectiveness of HBO in irradiated patients who require 
dental implants (28).
Discussion
According to these results, it was necessary to carry out 
a critical evaluation of the recommendations, in order to 
evaluate them under the light of the scientific evidence 
and, after a suitable analysis, to select those properly va-
lidated. Therefore, a number of recommendations could 
be given, based on the best available evidence (Table 4). 
It is evident that almost all centers advise patients to have 
a thorough dental exam before starting RT treatment in 
order to diagnose and treat possible existing pathologies. 
In addition, patients are advised to carry out a proper 
oral hygiene, nutrition and hydration, and also to avoid 
alcohol use and smoking. Nevertheless, only few centers 
emphasize how a proper oral hygiene must be carried 
out. Many centers specify the use of soft brush together 
with fluoride toothpaste, however, very few point out 
the need of interdental and tongue hygiene, and none of 
them specify which is the suitable technique for oral hy-
giene. In regards to mouth rinsing, many centers advise 
the patients to carry out rinses. Nevertheless. only few 
of them specify the rinse type and the frequency of use. 
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Only few centers advise the daily use of fluoride in cus-
tom trays to help to prevent dental decay, and the need 
to perform the proper dental treatments (prophylaxis, 
dental fillings, fit of dental prosthesis, etc.) in case they 
were necessary; as well as, the need of assessing, quanti-
tatively, the salivary flow. Ultimately, the decision on the 
type of oral-dental treatment is based on the clinical and 
radiographic assessment (including pulp and periodon-
tal problems) of the involved tooth, the available time 
before cancer treatment and the immune status of the 
patient, as well as the planned radiotherapy treatment 
(doses, area to be irradiated, etc.) (6). In those cases in 
BEFORE DURING  AFTER 
Clinical and oral radiographic  
examination 
Monitoring and management the 
oral effects of cancer treatment 
every week 
Regular dental examination every 3-4 
months
Multidisciplinary assessment  To keep a high level of oral 
hygiene 
To keep a high level of oral hygiene 
Proper oral hygiene instructions, 
 soft toothbrush, interdental hygiene,  
fluoride toothpaste 
To avoid teeth extractions or 
surgery 
Increased incidence of cavities, plaque 
and gingival index:  
-Fluoride products  
- CHX rinses 
Daily application 1.1% sodium 
fluoride custom tray 
Rinses 0.12% CHX (alcohol-free) To treat specific dental concerns 
(Prophylaxis, scaling and root 
planning, dental cavities, prosthesis, 
hypersensitivity…) 
Extractions: is not recommended at 
least 6-12months. HBO to reduce the 
risk ORN 
Supragingival prophylaxis or scaling 
and root planning treatment 
Mucositis prevention:
information, proper oral hygiene, 
avoid smoking and use alcohol, 
avoid poorly fitting prosthesis, 
adequate nutritional and hydration 
support. Cryotherapy, KGF-1, 
Benzydamine mouthwash 
Mucositis Treatment: Low 
intensity laser. Pain control: 
patient-controlled analgesia with 
morphine, 2% morphine 
mouthwash, 0.5% doxepin 
mouthwash 
ORN:
HBO appears to reduce the risk. HBO 
is used before surgery for up to as 
many 20 daily treatments. Surgery 
(removal necrotic tissue) is then 
followed by 10 daily postoperative 
HBO treatments to maximize healing
Caries treatment Candida ssp. Infection 
treatment: drugs totally or 
partially absorbed by the 
gastrointestinal tract (fluconazole) 
Trismus: mandibular exercises. 
Endodontic treatment Xerostomia: adequate nutritional 
and hydration support, avoid 
smoking and consuming alcohol, 
IMRT, stimulate saliva 
(pilocarpine), substitutes saliva 
Dental Implants: Higher rate failure.
Placement 1-2years post-RT, to wait
longer before loading 
To fit removable dental prosthesis 
Quantitative sialometry 
Measurement mouth opening 
Atraumatic teeth extractions with 
primary wound closure of teeth with 
poor prognosis, 10 to 14 days before 
radiotherapy. Blood Test: complete 
blood count (CBC) 

Table 4. Evidence-based oral care protocol for irradiated patients for head and neck cancer.
CHX, chlorhexidine; IMRT, intensity modulated radiotherapy; ORN, osteoradionecrosis; HBO: hyperbaric oxy-
gen; RT, radiotherapy.
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which dental extractions were necessary, only three cen-
ters point out the possible patterns to follow. However, 
within the information related to mentioned patterns, the 
healing period after tooth extraction and prior to irradia-
tion is not clearly enough pointed out in all of them. A 
healing period between 10-14 days should be granted, 
since a delayed bone healing after tooth extraction in 
irradiated HNC patients has been demonstrated (30).
The need of dental monitoring during the oncologic 
treatment is pointed out by very few centers. It is, howe-
ver, essential to carry it out in order to reduce and/or 
control the complications that may arise. As it can be 
seen when reviewing the IMRT literature, it is one of the 
measures that may contribute to reduce the incidence of 
complications that may arise, and to avoid any tooth ex-
traction or oral surgery during cancer treatment.
When the measures implemented by the different cen-
ters in case of mucositis were analysed, it was noted that 
many of them recommend that mouth washing must be 
carried out. Many active ingredients, or the combina-
tion of some of them, have been suggested for clinical 
use, but few RCTs have been carried out (4,5). Therefo-
re, these products must be used with caution since the 
combination of products from different mouth rinses 
can interact among them; in addition, excessive dilution 
can make them ineffective. The review of the literature 
reflects that, at present, the most effective measures in 
order to prevent mucositis are cryotherapy, keratinocy-
te growth factor and mouth rinsing with benzydamine 
hydrochloride. When mucositis is already established, 
the most recommendable way of treatment is the low-
intensity laser therapy. Little evidence-based literature 
exists on management strategies for oral mucositis pain. 
Topical anesthetics, such as viscous lidocaine, are used 
for mild to moderate pain. Systemic analgesics have 
been the cornerstone of pain management for patients 
with oral mucositis experiencing moderate to severe oral 
pain. The World Health Organization recommends mor-
phine sulfate as the opioid of choice. As to the candidia-
sis treatment, these infections usually respond well to 
antifungal but only one center points out the use it. Most 
of the hospitals inform the patient that xerostomia may 
arise, and emphasize in regards to keeping the suitable 
diet, hydration and oral care. However, very few centers 
recommend the application of ice and chewing sugarless 
gum or the use of saliva stimulants or substitutes.
As it can be seen in the tables, very few hospitals po-
int out the need of post-RT dental check-ups. Due to a 
higher incidence of decay, and increases in PI and GI 
(4), the importance of the check-ups should be stressed. 
Patients must be advised about the use of fluoridated 
products and to carry out rinses with CHX. Only few 
hospitals point out the possibility that ORN can occur 
and how to solve it. The scientific evidence indicates 
that IMRT and HBO may contribute to reduce the risk. 
In case of trismus, only three centers refer to this type of 
pathology. The dentist should measure in millimeters the 
distance that patients can open their mouth at baseline 
and periodically during the follow-up period, and guided 
exercises may help to prevent it. No hospital refers to 
the dental implant treatment, but RT induces changes in 
hard and soft tissues and these changes are harmful to 
implant survival. 
Conclusions
Heterogeneous and non-solidly scientifically based oral 
care recommendations are given by Hospitals in Madrid 
for irradiated HNC patients. According to the available li-
terature, an evidence-based protocol should include actions 
before, during and after cancer treatment: before, a multi-
disciplinary assessment and carrying out appropriate dental 
treatments to avoid complications; during, avoidance of 
tooth extraction or oral surgery, use of intensity-modulated 
radiotherapy, instructions to avoid smoking and alcohol 
use, and nutritional support and appropriate hydration; and 
after therapy, management of chronic complications and 
any relevant oral condition should be accomplished, taking 
into account the risk of osteoradionecrosis.
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